Cargando…
Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benz...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852433/ https://www.ncbi.nlm.nih.gov/pubmed/29385731 http://dx.doi.org/10.3390/jcm7020017 |
_version_ | 1783306570821533696 |
---|---|
author | Guina, Jeffrey Merrill, Brian |
author_facet | Guina, Jeffrey Merrill, Brian |
author_sort | Guina, Jeffrey |
collection | PubMed |
description | Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation. |
format | Online Article Text |
id | pubmed-5852433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58524332018-03-19 Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives Guina, Jeffrey Merrill, Brian J Clin Med Review Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation. MDPI 2018-01-30 /pmc/articles/PMC5852433/ /pubmed/29385731 http://dx.doi.org/10.3390/jcm7020017 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Guina, Jeffrey Merrill, Brian Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives |
title | Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives |
title_full | Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives |
title_fullStr | Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives |
title_full_unstemmed | Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives |
title_short | Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives |
title_sort | benzodiazepines i: upping the care on downers: the evidence of risks, benefits and alternatives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852433/ https://www.ncbi.nlm.nih.gov/pubmed/29385731 http://dx.doi.org/10.3390/jcm7020017 |
work_keys_str_mv | AT guinajeffrey benzodiazepinesiuppingthecareondownerstheevidenceofrisksbenefitsandalternatives AT merrillbrian benzodiazepinesiuppingthecareondownerstheevidenceofrisksbenefitsandalternatives |